Opin
30/06/22
Opyl joins forces with two key patient advocate groups
20/05/22
Clinical Trials Day 2022: Every day should be clinical trials day
06/05/22
Oriel Morrison interviews Michelle Gallaher, CEO of Opyl (ASX: OPL)
27/04/22
Twin contracts a validation of Opyl’s pivot to AI and the success of its flagship platform, Opin
31/01/22
Opin season arrives for patients as AI drives Opyl boom in Q2 receipts
30/08/21
Opyl is ready to scale up AI platform Opin after delivering full-year revenue growth
23/08/21
Stock Insiders Podcast: Investors eye Opyl’s strong revenues and expanded offering following launch of ‘Opin’ clinical trial recruitment platform
23/08/21
Why your clinical trial recruitment strategies are failing on social media
13/08/21
Opin making life saving information easier to find
02/07/21
Opyl reaches key milestone for its clinical trial recruitment platform Opin, shares jump
28/06/21
AI Platform Matches Patients to Trials
25/05/21